Judd Merrill
Analyst · Oppenheimer
Thank you, Steve. For the quarter ended September 30, 2019, we recognized revenue of approximately $2.4 million compared to $1.2 million in the third quarter of 2018. This represents a 102% increase for the current quarter as compared to the same quarter a year ago. It should also be noted that Q3 2019 revenue was 59% higher than Q2 2019 revenue. This is due to increased plant production with continuous operation of 4 modules, which currently resulted in higher production, Q3 revenues in line with expectations reflected operations on our initial 4 modules. Cost of products sales were $8.2 million in the quarter compared to $6.5 million in the year ago period. This represents a 28% increase. However, cost as a percentage of revenue decreased by 37%. This is a significant indicator that plant improvements are having these positive impacts on our costs. These costs were also impacted by addition of raw materials and supplies related to increased production by additional production employees in preparation for meeting the staffing requirement to enable the plant to operate its 16 modules. G&A for the third quarter 2019 was $5.1 million as compared to $2.2 million in the third quarter of 2018. Approximately 2/3 of G&A relates to noncash expense items including: $2.5 million accounted for shared payments, essentially it's debt equity shares and warrants related to the Veolia agreement for operations, maintenance and management services; and $0.8 million in noncash stock-based company compensation. Excluding the noncash items, our general and administrative expenses for the third quarter of 2019 were below expectations as a result of cost saving measures we put in place early in the year. We have identified additional savings of approximately $1 million in annual G&A cost reductions that we will begin to realize next year. We are committed to continually reviewing our costs and seek to make improvements wherever possible. Interest expense in Q3 was $142,000, that's 84% lower than the $992,000 recorded in the third quarter of 2018. This decrease is attributed to the convertible note held by Interstate Battery System International, Inc. that we paid off earlier this year. For the quarter ended September 30, 2019, we had an operating loss of $11.3 million compared to an operating loss of $8.4 million for the third quarter of 2018. The net loss for the third quarter of 2019 was $11.3 million or negative $0.20 per diluted share compared to a net loss of $9.3 million or negative $0.24 per diluted share in the third quarter of 2018. Our weighted average shares outstanding for the quarter increased to 57.1 million. As of September 30, 2019, the company had $15.5 million in cash and cash equivalents. Looking ahead, we are excited to see the progress on the final common configuration of all of our 16 modules. During the fourth quarter, we are focused on the complete installation of our Phase 2 construction project. During the third quarter, the company used $6.8 million of cash for operations and $5 million in cash for CapEx. Of course, additional capital will be needed in order to fund expected growth, continued increasing production of AquaRefined lead at the AquaRefinery, expand beyond the 16 modules, work with Clarios on equipment integration, develop our licensing business and to fund our operations until we are at positive cash flow. Management and the Board are committed to maximizing shareholder value. As a result, we are currently discussing: first, additional nondilutive options to obtain funds through various financing sources, including debt, equipment leasing, presell of our AquaRefined lead, licensing fees for our technology and/or project finances; and secondarily, options that include opportunistic sale of equity. Our strategy will be based on successfully getting the plant up and running at its full capacity, ensuring that we have the financing in place to allow for expansion and maximizing shareholder value. We have already received an approval from an equipment financing company for up to $5 million in equipment financing. The company intends to close on this CapEx funding in Q4 with the proceeds going towards funding CapEx needed to complete getting our plant up to capacity. We're also in discussions to presell our AquaRefined lead and other products for amount in equal to or greater than $5 million. With that, I'll turn it back to Steve.